|
(9) Biophysical Description of Age and Dose Dependent Changes to Dendritic Morphology that Impact Cognition following Radiation Cancer Therapy
|
5R01CA208526-02
|
$472,047
|
CUCINOTTA, FRANCIS
|
UNIVERSITY OF NEVADA LAS VEGAS
|
|
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblastoma
|
5R01CA190121-05
|
$362,088
|
VERHAAK, ROELAND
|
JACKSON LABORATORY
|
|
(PQ 9) Synaptic basis of deficits in attention and executive function following cranial radiation
|
5R01CA208535-02
|
$451,564
|
GROSSHANS, DAVID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQ1) Identifying and targeting human glioblastoma migrating in the peritumoral niche
|
1R01CA216054-01
|
$324,411
|
HAYDEN, MELANIE
|
STANFORD UNIVERSITY
|
|
(PQ1) Molecular circuit of multi-ciliogenesis regulates choroid plexus differentiation and tumor development
|
1R01CA220551-01
|
$383,749
|
ZHAO, HAOTIAN
|
SANFORD RESEARCH/USD
|
|
(PQ9) Directed and unbiased studies of synaptic injuries as sequelae of radiotherapy: mapping, sex-dependence, and reversal
|
1R01CA219667-01
|
$554,770
|
DUMAN, JOSEPH
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu
|
5R01CA185039-04
|
$373,436
|
JAN, LILY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
|
5R01CA194470-03
|
$446,627
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data
|
5R01CA185486-04
|
$517,690
|
RABADAN, RAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw
|
5R01CA185137-04
|
$882,372
|
CHAREST, ALAIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
(PQD-5) Patient derived orthotopic xenograft models for drug response prediction
|
5R01CA185402-04
|
$318,923
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQD3) Mechanisms of prolonged initial disease-free survival in glioblastoma
|
5R01CA184320-04
|
$738,276
|
SARKARIA, JANN
|
MAYO CLINIC ROCHESTER
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
2D MR Correlational Spectroscopy Platform for Molecular and Genetic Characterizations of Glioma
|
1R01CA203388-01A1
|
$427,689
|
MAO, HUI
|
EMORY UNIVERSITY
|
|
4-Channel Multimodal Ultrathin-Flexible SFE for cancer diagnosis and therapy
|
1R43CA211086-01A1
|
$300,000
|
MCMORROW, GERALD
|
VERAVANTI, INC.
|
|
5-hydroxymethylcytosine in human cancer
|
5R01CA160965-06
|
$394,250
|
PFEIFER, GERD
|
VAN ANDEL RESEARCH INSTITUTE
|
|
A CEST-MRI Reporter Gene for Image Guided Oncolytic Virotherapy
|
5R01CA203873-02
|
$406,309
|
FARRAR, CHRISTIAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
A clinically-relevant anti-CD27 agonist antibody as a vaccine adjuvant for brain tumor immunotherapy
|
5F31CA210535-02
|
$32,154
|
RICCIONE, KATHERINE
|
DUKE UNIVERSITY
|
|
A clone's genomic stability as biomarker of its DNA-damage resilience
|
1K99CA215256-01
|
$166,644
|
ANDOR, NOEMI
|
STANFORD UNIVERSITY
|
|
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers
|
5R33CA202900-02
|
$412,553
|
BREUNIG, JOSHUA
|
CEDARS-SINAI MEDICAL CENTER
|
|
A high content screen dissecting ciliogenesis and oncogenic Hedgehog signaling
|
5R01CA181231-02
|
$362,569
|
REITER, JEREMY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Mechanistic Understanding of Neuronal Activity Promotion of High-Grade Glioma Growth through Activity-Regulated Secretion of Neuroligin-3
|
5F31CA200273-03
|
$44,044
|
VENKATESH, HUMSA
|
STANFORD UNIVERSITY
|
|
A new class of CSF-1R radioligands for monitoring glioblastoma progression and therapy
|
1R21CA205564-01A1
|
$205,187
|
CHIN, FREDERICK
|
STANFORD UNIVERSITY
|
|
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors
|
1R01CA217956-01
|
$662,909
|
BRADY-KALNAY, SUSANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
|
1R01CA217179-01
|
$566,814
|
MARKERT, JAMES
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas
|
5R01CA198076-03
|
$1
|
PORTNOW, JANA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Prospective Study of Social Competence in Pediatric Brain Tumor Survivors
|
5K07CA178100-05
|
$129,957
|
HOCKING, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
A Unique Class of Reductively Activated Oncology Drugs
|
1R01CA208669-01A1
|
$718,986
|
BOGER, DALE
|
SCRIPPS RESEARCH INSTITUTE
|
|
A Vascularized, In Vitro, Organotropic Metastasis Model to Generate Dormant Micrometastases
|
1R21CA214299-01
|
$240,785
|
SLATER, JOHN
|
UNIVERSITY OF DELAWARE
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$703,174
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S1
|
$125,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S2
|
$62,491
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-41
|
$7,810,244
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Academic-Industrial Partnership to Develop Clinical Brain Cancer Imaging
|
5R01CA166171-05
|
$480,667
|
ZHOU, JINYUAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Adaptive resistance to HIF1a inhibition in hypoxia
|
5R01CA207377-02
|
$352,147
|
QIAN, ZHENG DAVID
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Adult Brain Tumor Consortium (ABTC)
|
5UM1CA137443-08
|
$1,998,892
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology
|
5R33CA206949-02
|
$475,865
|
SPICER, TIMOTHY
|
SCRIPPS FLORIDA
|
|
Advancing Treatments for Pediatric Craniopharyngioma (ATPC): Preliminary Assessment of the Cyst Fluid Inflammatory Milieu
|
1R03CA212800-01
|
$77,750
|
HANKINSON, TODD
|
UNIVERSITY OF COLORADO DENVER
|
|
AIDS Malignancy Consortium (AMC)
|
5UM1CA121947-11
|
$22,965,613
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-04
|
$11,145,123
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
An 18F PET/NIRF Smart Probe for Identifying, Grading, and Visualizing Astrocytic Gliomas
|
1F32CA213620-01
|
$57,066
|
HETTIE, KENNETH
|
STANFORD UNIVERSITY
|
|
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
|
5R01CA169345-05
|
$322,663
|
WALDMAN, TODD
|
GEORGETOWN UNIVERSITY
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
Barr, Frederic
|
CCR (NCI)
|
|
Angiogenesis-targeting therapy for glioblastoma
|
3R01CA129371-10S1
|
$251,370
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Angiogenesis-targeting therapy for glioblastoma
|
5R01CA129371-10
|
$592,913
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Apoptotic Proteins as Molecular Modulators of Stem Cell Fate
|
5R00CA178190-05
|
$249,000
|
GAMA, VIVIAN
|
VANDERBILT UNIVERSITY
|
|
Area A: Development of genetically tractable, driver gene-syngeneic brain tumor models for pre-clinical adoptive TCR-T therapy
|
1R33CA225328-01
|
$1,540,837
|
LI, QIJING
|
DUKE UNIVERSITY
|
|
Area B: Precise DCE-MRI Assessment of Brain Tumors
|
1R33CA225400-01
|
$1,561,994
|
NAYAK, KRISHNA
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Asymmetric cell division drives therapeutic resistance and self-renewal in glioblastoma
|
1R03CA215939-01
|
$79,250
|
HITOMI, MASAHIRO
|
CLEVELAND CLINIC LERNER COM-CWRU
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|